ARTICLE | Company News
Quest Pharma, BC Cancer Agency deal
February 4, 2008 8:00 AM UTC
The agency will investigate the anti-tumor effects of a combination of Quest Pharma’s SL052 with undisclosed immunotherapeutics to treat lung cancer. The partners will jointly own resulting IP, and Q...